GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Abbott Laboratories ABT · USD

Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States

S&P 500

Compare

110.51

+0.53%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

33 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 11Strong buy
  • 15Buy
  • 7Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Last close 110.51Average target 123.64

Low
92.00
Average
123.64
Median
121.00
High
145.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue$49.99bn$53.68bn$57.15bn$61.44bn$65.80bn
Revenue, highest$50.34bn$54.83bn$59.72bn$62.61bn$67.06bn
Revenue, lowest$49.17bn$52.03bn$53.81bn$59.48bn$63.70bn
Earnings per share5.525.936.507.217.94
Earnings per share, highest5.556.187.617.388.14
Earnings per share, lowest5.505.874.066.917.61
Analysts2021251212

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast1.431.291.161.511.311.271.081.36
Reported1.421.311.151.501.301.261.091.34
Difference-0.7%+1.4%-0.5%-0.7%-1.1%-0.6%+0.7%-1.2%

Rating changes

Latest broker notes

  • Wolfe ResearchPeer Perform → Outperform
  • UBSBuy
  • Wells FargoOverweight
  • TD CowenBuy
  • RBC CapitalOutperform
  • Piper SandlerOverweight
  • JP MorganOverweight
  • Evercore ISI GroupOutperform
  • CitigroupBuy
  • BTIGBuy
  • Evercore ISI GroupOutperform
  • Piper SandlerOverweight

Recent targets

Latest 12 months

  • Wolfe Research130.00
  • UBS125.00
  • Benchmark Co.120.00
  • Piper Sandler118.00
  • BTIG134.00
  • Evercore ISI112.00
  • Robert W. Baird121.00
  • Daiwa92.00

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

6 / 10

Revenue growth 8.1% a year over 10 years. Return on equity 12.5%.

Model fair value

116.75

From earnings 116.75, from revenue 127.06.

Piotroski score

5 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.